✦ LIBER ✦

Clinical outcomes in sarcoidosis after cessation of infliximab treatment

✍ Scribed by Efstratios PANSELINAS; J. Keith RODGERS; Marc A. JUDSON

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prediction of relapse after discontinuat

✍ Vorselaars, A. D. M.; Verwoerd, A.; van Moorsel, C. H. M.; Keijsers, R. G. M.; R 📂 Article 📅 2013 🏛 European Respiratory Society 🌐 English ⚖ 355 KB

Trough serum infliximab: a predictive fa

✍ Seow, C. H. (author);Newman, A. (author);Irwin, S. P. (author);Steinhart, A. H. 📂 Article 📅 2009 🏛 BMJ Publishing Group 🌐 English ⚖ 351 KB

Trough serum infliximab: a predictive fa

✍ Seow, C. H. (author);Newman, A. (author);Irwin, S. P. (author);Steinhart, A. H. 📂 Article 📅 2009 🏛 BMJ Publishing Group 🌐 English ⚖ 351 KB

Persistent fistula tracks in perianal Cr

✍ Gert A. Van Assche; Dirk Vanbeckevoort; Didier Bielen; Geert D'Haens; Andre D'Ho 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Crohn's Disease: Infliximab Trough Level

✍ David Drobne; Peter J. Bossuyt; Christine Breynaert; Niels Vande Casteele; Griet 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Association of Trough Serum Infliximab t

✍ Maser, Elana A.; Villela, Renata; Silverberg, Mark S.; Greenberg, Gordon R. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 211 KB